The PEPD gene gives your body instructions to make prolidase, an enzyme that helps break down and recycle protein pieces needed for healthy skin and connective tissue. This gene helps your body repair tissue and support normal growth. When the PEPD gene does not work properly, it can cause prolidase deficiency, a rare inherited condition linked to slow wound healing, repeated infections, skin ulcers, and sometimes developmental differences. Effects can vary widely from person to person.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or managing activities in the body. Some genes carry the directions for producing proteins, which do much of the cell's work. Others mainly regulate when certain activities happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you react to food, stress, and medicines. You can find more detailed information on this topic in the LearnHub.
Overview
PEPDGene function
What if the gene works
The PEPD gene helps your body recycle parts of collagen, a protein that gives strength to skin, joints, bones, and blood vessels. This supports tissue repair and steady growth and healing.
Risk
What if the gene does not work
Variants in the PEPD gene can cause prolidase deficiency, often leading to chronic skin sores, repeated infections, and developmental delay. Effects range from mild to more severe, and the age of onset and features can vary.
Treatment
What does that mean for your treatment
For people with pathogenic variants in the PEPD gene, no treatment or management approach linked specifically to PEPD is currently established. Care is based on symptoms rather than the gene itself, while enzyme replacement and gene therapy are still being studied.
Conditions associated with PEPD
Gene function
What if the gene works
Your cells are always breaking down and reusing old protein pieces. The PEPD gene helps with one of the last cleanup steps, especially for pieces rich in proline, a building block common in collagen. This is part of how the PEPD gene helps break down collagen fragments during normal tissue turnover.
PEPD makes an enzyme called prolidase that cuts apart short protein fragments at a very specific final step. It targets fragments that end in proline or hydroxyproline, two amino acid building blocks commonly found in collagen.
By freeing these building blocks, the PEPD gene helps your body reuse material from old collagen. This supports routine upkeep of skin, connective tissue, bones, and blood vessel walls.
The released proline can be used again to build new proteins your cells need each day. This helps cells use materials efficiently during growth, tissue renewal, and routine maintenance.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PEPD gene can change the prolidase protein so it folds poorly, becomes unstable, or has little to no enzyme activity. Understanding how PEPD gene variants affect prolidase enzyme activity helps explain why their impact can vary: some missense variants leave partial function, while more disruptive variants, such as stop, frameshift, or certain splice variants, may sharply reduce or eliminate the protein. Lower remaining activity often links to earlier or more pronounced prolidase deficiency, although severity can vary between people.
How variants are linked to conditions
Pathogenic variants in both copies of the PEPD gene cause prolidase deficiency, a rare inherited condition. In practical terms, PEPD gene variants linked to prolidase deficiency can be associated with chronic skin ulcers, repeated infections, enlarged spleen, and variable developmental or learning difficulties, though symptoms differ widely from person to person. Carrying one variant usually does not cause the condition.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common across the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For the PEPD gene, risk is mainly shaped by whether someone inherits changed copies from both parents, and there is not yet broadly confirmed evidence that lifestyle or everyday exposures meaningfully change that genetic risk. Anyone with questions about personal or family risk can speak with a doctor or genetic counselor.
Inheritance of PEPD variants
PEPD-related prolidase deficiency follows an autosomal recessive inheritance pattern. This means a child inherits one PEPD variant from each parent, and parents who each carry one variant are usually unaffected carriers. When both parents are carriers, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, how PEPD variants are inherited is the same for sons and daughters.
What does my PEPD result mean for my family?
For families with a disease-causing change in the PEPD gene, close relatives may also carry the same change or, less often, also be affected. Brothers and sisters can have a higher chance of sharing the condition, while parents are often healthy carriers. Other family members, such as future children of relatives, may also be affected by whether they carry a PEPD change.
Genetic information
Genetic testing
How you find out about variants
PEPD genetic testing for prolidase deficiency uses a blood, saliva, or cheek swab sample to look for variants in the PEPD gene. A laboratory reads the gene's DNA sequence to find changes that may confirm the diagnosis or explain a family history. Results may show a disease causing variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the PEPD gene may be worth considering if someone has repeated skin sores that heal poorly, frequent infections, or developmental delays from childhood, which can happen in a rare inherited condition called prolidase deficiency. It can also help when the condition runs in the family or both parents are known carriers.
A genetic result is only one part of your health story
Genetic findings can be informative, although the amount they reveal varies with the condition and the specific kind of variant. Over time, the body is also shaped by factors including lifestyle, surroundings, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than a definite conclusion and makes the most sense when considered with other parts of care. In other situations, a genetic finding can give a clear answer. For topics like medication response, these results can also help make sense of personal experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same medication may work well for one person, cause more side effects in another, or have less effect in someone else. These differences are common and often relate to how the body breaks down, transports, or responds to a drug.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way medicines work. By studying gene-drug relationships, it helps explain why the same treatment can have different effects in different people. For many drugs, genes can influence both how the body handles a medicine and how much effect that medicine has. This information can support treatment choices that are better informed and more personalized. More detail on this subject is available in the LearnHub.
Drugs influenced by the PEPD gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines, so general concerns about side effects, treatment changes, or new symptoms are best discussed with your doctor.
History
PEPD entered medical research through studies of prolidase deficiency, a rare inherited condition first recognized from its clinical and laboratory features before the gene itself was identified. Initially understood only through visible traits, later recognized as tied to a specific gene, this work grew out of biochemical studies showing very low or absent prolidase enzyme activity in affected families. Building on this early work, scientists mapped and then identified the PEPD gene in the 1980s and 1990s, which clarified the inherited basis of the condition. That discovery made it possible to confirm the diagnosis with DNA testing rather than enzyme testing alone. Over time, descriptions became more precise as more PEPD variants were reported in people from different populations.